Background: No genetic defects are found in the coagulation factor VIII gene (F8) of
| INTRODUCTION
shown that no genetic mutations in F8 can be found in approximately 2% of patients with hemophilia A. [2] [3] [4] In cases such as these, it is believed that mutations could be located deep within the introns of F8. Recently, we unexpectedly detected the c.1537+325A>G mutation within intron 10 by genomic DNA analysis. 5 We also detected the c.1443+602A>G mutation within intron 9 by mRNA analysis. 6 Both variants were predicted to cause a splicing abnormality by in silico analysis, and the abnormal transcripts were confirmed through mRNA analysis. Moreover, another study reported the existence of a causative variant located deep within an intron of the F8. 7 The objective of the present study was to establish a method of whole-genetic analysis of the sequence of F8 using NGS and investigate the variants located deep within its introns.
| MATERIALS AND METHODS

| Patient samples
Genomic DNA was extracted from peripheral blood cells of patients.
Forty-five Japanese male patients with hemophilia A were investigated. These patients were confirmed to not have any apparent 
| Next-generation sequencing
The complete F8 locus was amplified in 14 overlapping regions (5-23 kb) by LR-PCR using KOD FX neo (Toyobo Co., Ltd, Osaka, Japan). The primers used are shown in Table S1 . Amplification was performed based on two-step touch-down PCR. Thermal cycling conditions are shown in Table S2 . In total, approximately 197 kb (including the upstream and downstream regions of F8) were amplified.
The PCR fragments were purified using an illustra GFX PCR DNA 
| Inversion analysis
F8 inversion was analyzed by the long-range PCR method described by Liu et al., 8 with modifications. Briefly, the primers were designed more adequately and step-down amplification was adopted.
| Bioinformatic analyses
Two detection tools, BreakDancer 9 and Pindel, 10 were used to detect structural variants.
Essentials
• Intronic variants of the factor VIII gene (F8) causing hemophilia A have been reported.
• We established an analysis method for whole F8 and investigated the variants within its introns.
• Rare variants located within introns of F8 in patients with hemophilia A are not uncommon.
• The c.6429+14194T>C variant was characteristically detected in patients with inversion. 
| NGS data and analysis
Sequencing coverage was sufficiently high (>20 reads) to confirm the sequence, although it varied widely by region and analysis ( Figure 1 ).
However, a small part of intron 22, which differed in size (~1-2 kb)
according to sample and analysis, showed very low coverage (0-20 reads). The low-coverage region correspond to F8A1 (coagulation factor VIII-associated 1) gene and had a high GC content. Our NGS analysis therefore allowed for the identification of genetic variants within roughly 99% of F8. On average, 140 variants were detected in each patient. In the analysis of samples that were previously identified as having causative mutations, it was confirmed that the single nucleotide variants (such as point mutations) and small deletions could be detected with high accuracy and efficiency (Table 1 ). In contrast, structural variants (such as inversions and large duplications) could not be appropriately detected by bioinformatic analyses under the present conditions. F8 appears to be susceptible to genetic rearrangements for the following reasons: (i) F8 is very large and contains a large number of repetitive elements (e.g, Alu repeats and long interspersed elements); and (ii) F8 is located on the tip of the X chromosome.
Therefore, it becomes very effective in causative mutation analysis of hemophilia if we can detect not only single nucleotide substitution, but also structural variant by NGS. Further studies are required to detect structural variants.
| Variant analysis
To search for rare and causative variants located within the introns of F8, we narrowed down the variants. At first, in the VariantStudio software annotation, the variants were filtered by the following criteria: (i) "homozygote" (meaning hemizygote on the X chromosome of males) was applied to the category of "Genotype"; (ii) "PASS" (meaning all filters about the quality of variant call were passed in the VCF [Variant Call Format] file annotations) was applied to the category of "Filters"; and (iii) "no" was applied to the category of "Exonic" (meant intronic (Table 2A) . Although two duplication variants, c.5219+10174dupA and c.1903+2003dupT, passed through the VCF filters, the possibility of them being false positive variants cannot be excluded because they were located at a homopolymer sequence.
In the present study, we did not validate the detected variants.
This is because we selected variants that were detected with high alternative variant frequency (approximately 100%) and recognized as homozygous. However, a concern of NGS for long-range amplified material is the appearance of false positive variants because of replication errors in PCR. Therefore, we believe that validation by Sanger sequencing is necessary when analyzing variants with low alternative variant frequency.
To predict the functional annotation of these variants, we first attempted to evaluate the variants by CADD analysis ( Table 2 ). The C-scores of these variants obtained by the analysis ranged from 0.005 to 14.97. Four considerably high scores (over 10), were observed in four patients. According to these results, these four variants might To investigate the effects of each variant on splicing, we performed in silico analysis using three types of prediction software (Table 2) .
However, a prediction by each algorithm did not accord in almost all specific variants, and did not lead to firm prediction results. This indicated that an alternative approach to verify the effect of splicing is necessary.
| Analysis of the patients without detectable mutation in F8
One of the two patients without detectable mutations in F8 carried a unique individual variant, c.144-10810T>C, in intron 1 with a Cscore of 13.56 (patient 1; Table 2A ), which was considerably high. In the analysis of the other patient with unknown causative mutation, no variant remained after the aforementioned filtering. However, the patient carried a unique individual variant, c.6723+193G>A, in intron 24 with a C-score of 13.3 (patient 28; Table 2B ). No significant splicing alteration was predicted by the in silico analysis. The variant was registered in the dbSNP as rs782551397, although the minor allele frequency and clinical significance were unavailable in the database. Therefore, it remains unclear whether 6723+193G>A is a causative mutation.
In the present study, we evaluated disease causality of each variant detected in the F8 by several in silico analyses: CADD, PredictSNP2, and three types of splicing prediction software. Pezeshkpoor et al.
reported an analysis of deep intronic mutations using NGS in patients without detectable mutations in F8 cDNA. 17 Their methodology combined analysis by NGS and of mRNA. They identified two intronic variants (c.5998+530C>T and c.5998+941G>A) that create new cryptic sites that lead to the insertion of intronic sequences in F8 mRNA. In addition, they mentioned the necessity of verification of the splicing by experimental approaches, because the inconsistency between different algorithms in predicting the effect of specific variations on splicing was confirmed. Bach et al. also reported a study on deep intronic variants using NGS. 18 They identified deep intronic variants in 15 out of 15 patients with mild to moderate hemophilia A whose disease-causing mutations were not identified by conventional methods. Subsequently, the authors reported results confirming the impact of the variants on splicing using the mini-gene assay. 19 They reported that there were inconsistent results between in silico prediction and the mini-gene assay. Together, these reports indicated that predicting splicing by in silico analysis with complete reliability is difficult, and experimental verification is necessary. Further studies are necessary to determine the effects on splicing of the variants that we identified.
| Inversion analysis
A total of nine patients included in the present study carried the intron 22 inversion. Seven of these cases were previously detected by long-range PCR. The remaining two cases also were detected by long-range PCR in the present study. To identify the inversion by NGS analysis, we attempted in silico analysis using two software programs (BreakDancer and Pindel). Unfortunately, they did not predict the inversion precisely. A considerable false-positive detections and insufficient reproducibility were confirmed. However, we identified an interesting variant, c.6429+14194T>C, within the int22h-1 sequence, which is responsible for homologous recombination. This variant was detected in eight out of nine patients with inversion and was detected in one out of 37 patients without inversion. Therefore, the sensitivity, specificity, and positive predictive value for the prediction of inversion within the cohort by detection of this variant were 88.9%, 97.3%, and 88.9%, respectively.
| CONCLUSIONS
In the present study, we established a method of whole-genetic T A B L E 2 Rare and unique individual variants detected in introns of the factor VIII gene from patients with hemophilia A. The variants that passed all filtering criteria (A) and the variant detected in a patient with unknown causative mutation (B) 
